170 related articles for article (PubMed ID: 15550349)
1. Neuroplasticity: from MRI to depressive symptoms.
Fossati P; Radtchenko A; Boyer P
Eur Neuropsychopharmacol; 2004 Dec; 14 Suppl 5():S503-10. PubMed ID: 15550349
[TBL] [Abstract][Full Text] [Related]
2. Does neurotropin-3 have a therapeutic implication in major depression?
Pae CU; Marks DM; Han C; Patkar AA; Steffens D
Int J Neurosci; 2008 Nov; 118(11):1515-22. PubMed ID: 18853330
[TBL] [Abstract][Full Text] [Related]
3. Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies.
Drzyzga ŁR; Marcinowska A; Obuchowicz E
Brain Res Bull; 2009 Jun; 79(5):248-57. PubMed ID: 19480984
[TBL] [Abstract][Full Text] [Related]
4. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior.
Schmidt HD; Duman RS
Behav Pharmacol; 2007 Sep; 18(5-6):391-418. PubMed ID: 17762509
[TBL] [Abstract][Full Text] [Related]
5. [Neuroplasticity and depression].
Czéh B; Simon M
Psychiatr Hung; 2005; 20(1):4-17. PubMed ID: 16389729
[TBL] [Abstract][Full Text] [Related]
6. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat.
Sairanen M; O'Leary OF; Knuuttila JE; Castrén E
Neuroscience; 2007 Jan; 144(1):368-74. PubMed ID: 17049169
[TBL] [Abstract][Full Text] [Related]
7. Depression-related variation in brain morphology over 3 years: effects of stress?
Frodl TS; Koutsouleris N; Bottlender R; Born C; Jäger M; Scupin I; Reiser M; Möller HJ; Meisenzahl EM
Arch Gen Psychiatry; 2008 Oct; 65(10):1156-65. PubMed ID: 18838632
[TBL] [Abstract][Full Text] [Related]
8. Alterations of neuroplasticity in depression: the hippocampus and beyond.
Fuchs E; Czéh B; Kole MH; Michaelis T; Lucassen PJ
Eur Neuropsychopharmacol; 2004 Dec; 14 Suppl 5():S481-90. PubMed ID: 15550346
[TBL] [Abstract][Full Text] [Related]
9. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
Manji HK; Duman RS
Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
Kozisek ME; Middlemas D; Bylund DB
Pharmacol Ther; 2008 Jan; 117(1):30-51. PubMed ID: 17949819
[TBL] [Abstract][Full Text] [Related]
11. BDNF in schizophrenia, depression and corresponding animal models.
Angelucci F; Brenè S; Mathé AA
Mol Psychiatry; 2005 Apr; 10(4):345-52. PubMed ID: 15655562
[TBL] [Abstract][Full Text] [Related]
12. [Depression and treatment. Apoptosis, neuroplasticity and antidepressants].
Arantes-Gonçalves F; Coelho R
Acta Med Port; 2006; 19(1):9-20. PubMed ID: 16987439
[TBL] [Abstract][Full Text] [Related]
13. The stress system in the human brain in depression and neurodegeneration.
Swaab DF; Bao AM; Lucassen PJ
Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
[TBL] [Abstract][Full Text] [Related]
14. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
Emond V; Joyal C; Poissant H
Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
[TBL] [Abstract][Full Text] [Related]
15. [Memory coding and retention: brain-derived neurotrophic factor (BDNF) in synaptic plasticity].
Gómez-Palacio Schjetnan A; Escobar-Rodríguez ML
Rev Neurol; 2007 Oct 1-15; 45(7):409-17. PubMed ID: 17918107
[TBL] [Abstract][Full Text] [Related]
16. Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis.
Jann MW
Pharmacotherapy; 2004 Dec; 24(12):1759-83. PubMed ID: 15585443
[TBL] [Abstract][Full Text] [Related]
17. Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy.
Taylor SM
J ECT; 2008 Jun; 24(2):160-5. PubMed ID: 18580563
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function.
Ding Q; Vaynman S; Akhavan M; Ying Z; Gomez-Pinilla F
Neuroscience; 2006 Jul; 140(3):823-33. PubMed ID: 16650607
[TBL] [Abstract][Full Text] [Related]
19. From restoration of neuroplasticity to the treatment of depression: clinical experience.
Costa e Silva JA
Eur Neuropsychopharmacol; 2004 Dec; 14 Suppl 5():S511-21. PubMed ID: 15550350
[TBL] [Abstract][Full Text] [Related]
20. Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection.
Bravo JA; Díaz-Veliz G; Mora S; Ulloa JL; Berthoud VM; Morales P; Arancibia S; Fiedler JL
Behav Pharmacol; 2009 May; 20(3):273-85. PubMed ID: 19424057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
